In January, US President George W. Bush signed into law the NIH Reform Bill, the first such overhaul of the NIH in the past 13 years. Though NIH funding will remain relatively flat in 2007, the bill will shift funding policy and essentially give Director Elias Zerhouni control of an eventual five percent of the agency’s total annual budget.

Though the budget increase is good news for systems biology, there is concern that the new focus on cross-agency research will come at the cost of established programs at NIH’s individual institutes and centers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.